Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTM-001 in Patients With Hidradenitis Suppurativa
NCT05020730Phase 2Unknown
- Sponsor
- Phoenicis Therapeutics
- Start
- May 2022
- Primary completion
- Dec 2023
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of PTM-001 in hidradenitis suppurativa (HS), sponsored by Phoenicis Therapeutics. Status: unknown.
02
Drugs
PTM-001
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT05020730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05020730.